NCT06086769

Brief Summary

The use of high-flow nasal cannula (HFNC) has increased. Diaphragmatic ultrasonography is a tool that, as a noninvasive complement to esophageal pressure (Pes) measurement, allows the evaluation of diaphragm function and reflects, through the diaphragm thickening fraction (DTf), the magnitude of diaphragmatic fiber recruitment. The objective of this study was to evaluate the impact of HFNC therapy on the DTf in healthy subjects. Second, this study aimed to assess the behavior of the respiratory rate (RR) and the work of breathing in these subjects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable healthy-volunteers

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable healthy-volunteers

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

September 29, 2023

Completed
18 days until next milestone

First Posted

Study publicly available on registry

October 17, 2023

Completed
Last Updated

October 17, 2023

Status Verified

October 1, 2023

Enrollment Period

3 months

First QC Date

September 29, 2023

Last Update Submit

October 11, 2023

Conditions

Keywords

High flow nasal canulaHigh flow nasal canula therapyDiaphragm thickening fractionWork of breathingRespiratory rate

Outcome Measures

Primary Outcomes (1)

  • Diaphragm thickening fraction.

    ultrasound measurements were performed by an expert operator (the same in all cases). The ultrasound measurement was performed using a high-resolution linear transducer in real-time in B-mode. The diaphragm thickness was measured at the end of expiration and the end of inspiration of the same ventilatory cycle and the average value of 3 ventilatory cycles was recorded. A 2-minute washout period was allowed between each test condition to avoid the summation of effects. The DTf and PTPes/min were calculated for each subject in each available condition (baseline - without flow- , wtih 20 and 40 liters per minute): DTf = End Inspiratory Diaphragm thickening - End Expiratory Diaphragm thickening / End Expiratory Diaphragm thickening x 100

    Immediately after 5 min of each condition (baseline, 20 and 40 liters per minute) the diaphragmatic thickness was measured at the end of inspiration y de la expiration during 3 consecutive respiratory cycles (each cycle is between 3 and 10 seconds)

Secondary Outcomes (3)

  • Respiratory Rate

    The number of breaths per minute was recorded in 60 seconds.

  • Esophageal pressure swing (Pes).

    5 minutes each condition

  • Esophageal pressure-time product per minute (PTPes/min).

    Through study completion, an average of 24 weeks

Interventions

Measurement of diaphragm thickening fraction, respiratory rate and esophageal pressure swing with calculation of diaphragmatic pressure-time product without the use of HFNC and with the use of HFNC at 20 and 40 Liters per minute

Also known as: diaphragm thickening fraction, esophageal pressure swing, Respiratory rate

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • healthy subjects over 18 years old

You may not qualify if:

  • contraindication for esophageal balloon placement
  • diagnosis of lung disease
  • smokers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Britanico de Buenos Aires

Ciudad Autónoma de Buenos Aires, Buenos Aires, 1280AED, Argentina

Location

MeSH Terms

Interventions

Respiratory Rate

Intervention Hierarchy (Ancestors)

Vital SignsPhysical ExaminationDiagnostic Techniques and ProceduresDiagnosisRespirationRespiratory Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Study Officials

  • Gustavo A Plotnikow, RT

    Hospital Británico de Buenos Aires

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

September 29, 2023

First Posted

October 17, 2023

Study Start

March 1, 2022

Primary Completion

May 30, 2022

Study Completion

June 30, 2022

Last Updated

October 17, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will share

Locations